STYK1 and pancreatic neoplasm: Disrupting STYK1-β-catenin or STYK1-GSK3β interaction significantly inhibits GSK3β sequestration, subsequent Wnt/β-catenin signaling, and pancreatic cancer development (Supplementary Fig. 9).